These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3422560)

  • 41. Flow cytometric monitoring of anthracycline transport in tumor cells.
    Krishan A
    Ann N Y Acad Sci; 1986; 468():80-4. PubMed ID: 3460483
    [No Abstract]   [Full Text] [Related]  

  • 42. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
    Umezawa K; Kunimoto S; Takeuchi T
    Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and antitumor activity of olivomycin A analogues.
    Kumar V; Remers WA; Bradner WT
    J Med Chem; 1980 Apr; 23(4):376-9. PubMed ID: 7381837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New anthracycline derivatives from betaclamycin A.
    Yoshimoto A; Matsuzawa Y; Ishikura T; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1984 Aug; 37(8):920-2. PubMed ID: 6480506
    [No Abstract]   [Full Text] [Related]  

  • 46. Studies on the cytotoxicity of asterriquinone derivatives.
    Kaji A; Iwata T; Kiriyama N; Nomura M; Miyamoto K
    J Antibiot (Tokyo); 1998 Feb; 51(2):235-8. PubMed ID: 9544948
    [No Abstract]   [Full Text] [Related]  

  • 47. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro.
    Inaba M; Nagashima K
    Jpn J Cancer Res; 1986 Feb; 77(2):197-204. PubMed ID: 3082832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modes of resistance to anthracyclines and other natural products.
    Kessel D; Romine M; Decker D
    Prog Clin Biol Res; 1986; 223():81-93. PubMed ID: 3543948
    [No Abstract]   [Full Text] [Related]  

  • 49. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
    Klohs WD; Steinkampf RW; Havlick MJ; Jackson RC
    Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular accumulation and disposition of aclacinomycin A.
    Egorin MJ; Clawson RE; Ross LA; Schlossberger NM; Bachur NR
    Cancer Res; 1979 Nov; 39(11):4396-400. PubMed ID: 498071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Continuous mixing experiments allow to determine the size of binding sites for anthracyclines complexed to DNA.
    Walter A
    Biomed Biochim Acta; 1985; 44(9):1321-7. PubMed ID: 3866577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distribution and metabolism of adriamycin in mice. Comparison with daunomycin.
    Di Fronzo G; Gambetta RA; Lenaz L
    Rev Eur Etud Clin Biol; 1971; 16(6):572-6. PubMed ID: 5125106
    [No Abstract]   [Full Text] [Related]  

  • 53. Arugomycin, a new anthracycline antibiotic. II. Structural elucidation.
    Kawai H; Hayakawa Y; Nakagawa M; Furihata K; Seto H; Otake N
    J Antibiot (Tokyo); 1987 Sep; 40(9):1273-82. PubMed ID: 3479413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of the molecular structure of anthracycline compounds on their intercalation into DNA].
    Brikenshteĭn VKh; Baranov EP; Pitina LR; Bushelev SN
    Bioorg Khim; 1985 Jul; 11(7):934-43. PubMed ID: 3863621
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural quinones as quinonemethide precursors--ideas in rational drug design.
    Moore HW; Czerniak R; Hamdan A
    Drugs Exp Clin Res; 1986; 12(6-7):475-94. PubMed ID: 3461932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New cyanomorpholinyl byproduct of doxorubicin reductive alkylation.
    Acton EM; Tong GL; Taylor DL; Filppi JA; Wolgemuth RL
    J Med Chem; 1986 Jul; 29(7):1225-30. PubMed ID: 3806572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of anthracycline antibiotics with biopolymers: comparative studies of DNA binding and antimicrobial activity of rhodomycin-type anthracycline antibiotics.
    Stutter E; Walter A; Fleck WF
    J Basic Microbiol; 1986; 26(10):607-20. PubMed ID: 3108489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Release of the cyano moiety in the crystal structure of N-cyanomethyl-N-(2-methoxyethyl)-daunomycin complexed with d(CGATCG).
    Saminadin P; Dautant A; Mondon M; Langlois D'estaintot B; Courseille C; Précigoux G
    Eur J Biochem; 2000 Jan; 267(2):457-64. PubMed ID: 10632715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversal of multidrug resistance by non-antitumor anthracycline analogs.
    Inaba M; Nagashima K; Sakurai Y; Fukui M; Yanagi Y
    Gan; 1984 Dec; 75(12):1049-52. PubMed ID: 6597118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The antibiotic galtamycin. Its fermentation, isolation, physicochemical and biological properties].
    Korobkova TP; Singal EM; Ivanitskaia LP; Kudinova MK; Karbyshev VD
    Antibiot Med Biotekhnol; 1986 Jun; 31(6):428-31. PubMed ID: 3461745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.